Releases
Found 19256 articles
PHBS Salon Tackles Climate-Trade Tensions in Shenzhen
Nearly 100 scholars and policymakers converged in Shenzhen on June 16 to address the friction between climate policy and international trade. The Carbon Economics Salon at Peking University HSBC Business School examined how unilateral green measures and carbon market disparities are reshaping global economic rules.
Desay SV and VfL Wolfsburg Forge Strategic Partnership
A new alliance between global mobility firm Desay SV and German football club VfL Wolfsburg aims to blend high-tech automotive innovation with community-focused sports initiatives. The partnership, announced July 27, 2026, seeks to deepen the technology company's European footprint while expanding social programs across international markets.
HoneyNaps pivots to CRO status to scale AI-driven sleep analytics
With the global clinical sleep market surging toward a projected USD 36.9 billion valuation by 2034, Boston-based HoneyNaps has officially registered as a Contract Research Organization with the Korea National Enterprise for Clinical Trials, positioning its AI technology at the center of international pharmaceutical and digital health research.
Cyient Promotes Andrew Smith to COO to Lead Global Operations
After nine years within the company’s transportation and semiconductor divisions, Andrew Smith has been appointed Chief Operating Officer at Cyient. The move signals a strategic push toward scaling next-generation delivery models and refining operational agility as the engineering firm eyes its next phase of global growth.
CobbleStone Schedules LinkedIn Live for Pharma Contract Management
Navigating the complex regulatory landscape of the pharmaceutical and biotech sectors requires more than manual tracking. On July 29, 2026, at 2:00 PM (ET), CobbleStone Software will host a 15-minute LinkedIn Live event to demonstrate how specialized contract lifecycle management tools can streamline compliance and internal collaboration.
Villa Vie Expands Residential Fleet with Legacy Launch
As Villa Vie Odyssey marks two years of continuous global travel, the company is doubling down on its residential maritime model. It announced Legacy, a second vessel scheduled for 2029, as demand for its initial ship pushes occupancy past the 85% threshold among those seeking a permanent life at sea.
American Industrial Partners Takes Avanos Medical Private in $1.27 Billion Deal
Avanos Medical stockholders will receive $25.00 per share in cash following the completed acquisition by American Industrial Partners, a move that transitions the medical technology firm from a publicly traded entity on the New York Stock Exchange to a private company in a deal valued at approximately $1.272 billion.
Blackbaud and Student First Expand Partnership for Connected Campus AI
Colleges and universities are facing mounting pressure to streamline operations, leading Blackbaud and Student First to launch a strategic innovation partnership. By integrating AI-powered student information systems with financial and advancement platforms, the companies aim to replace fragmented campus infrastructure with a unified, data-driven operating model.
Black Rock Coffee Faces Class Action Over IPO Sales Cannibalization
Investors have launched a securities class action against Black Rock Coffee Bar, alleging the company misled shareholders about the impact of its aggressive expansion strategy. The lawsuit claims that new store openings significantly cannibalized existing high-volume locations, contradicting assurances made during the firm's September 2025 initial public offering.
Trinity Capital Moves Listings to New York Stock Exchange
The Phoenix-based alternative asset manager Trinity Capital officially transitioned its common stock and senior notes to the New York Stock Exchange and NYSE Texas this week. The strategic move aims to elevate the firm's visibility among institutional investors while aligning its market presence with other major financial institutions.
ADMA Biologics Faces Securities Fraud Class Action Over Revenue Claims
Investors are lining up to join a securities fraud class action against ADMA Biologics following allegations that the company artificially inflated its stock price. The lawsuit, filed in the wake of a scathing short-seller report, claims the firm misled shareholders regarding its financial health and distribution practices between 2024 and 2026.
Primoris Services Faces Class Action Over Renewable Project Failures
A securities class action lawsuit has been filed against Primoris Services Corporation, alleging the company misled investors regarding its ability to manage large-scale renewable energy projects. The litigation, which targets executives for systemic reporting failures, follows a dramatic loss of over $6 billion in market capitalization since early May.
Hagens Berman Launches Investigation Into Peabody Energy Over Mine Delays
A class action lawsuit alleges that Peabody Energy misled shareholders about the operational viability of its Centurion mine in Queensland, Australia. Hagens Berman, a national shareholder rights firm, is now investigating whether management knowingly downplayed mechanical and production failures that ultimately triggered significant stock price declines for investors.
GeneDx Investors Face August Deadline in Securities Fraud Class Action
Investors who held GeneDx Holdings Corp. stock during the past year face an August 3, 2026, deadline to join a class action lawsuit. The litigation centers on allegations that the company misled shareholders regarding the integration of Fabric Genomics, ultimately triggering a 49% single-day stock price collapse.
Hagens Berman Launches Class Action Investigation into Hub Group
Investors who suffered losses in Hub Group, Inc. between April 2023 and May 2026 are under a looming August 28 deadline to lead a securities class action lawsuit. The firm Hagens Berman is investigating allegations that the company misled shareholders through systemic accounting irregularities and failed internal financial controls.
Regeneron Faces Securities Lawsuit After Failed Melanoma Trial
A $11 billion collapse in market capitalization has triggered a class action lawsuit against Regeneron Pharmaceuticals, following the company's disclosure that a late-stage clinical trial for its melanoma therapy failed to meet primary efficacy goals, leaving investors who purchased stock between August 2025 and May 2026 facing significant losses.
Investors Face Losses as PicS N.V. Faces Securities Class Action
Investors who purchased PicS N.V. stock following the company's January 30, 2026, initial public offering are now navigating a securities class action lawsuit. Hagens Berman is investigating allegations that the firm concealed critical flaws in its credit underwriting processes, leading to a significant collapse in share price.
Verra Mobility Investors Face Losses After Avis Contract Collapse
A 71 percent single-day stock crash has triggered a securities fraud class action lawsuit against Verra Mobility Corporation. The litigation follows allegations that executives misled shareholders about the stability of key partnerships, specifically concealing the precarious nature of a critical contract with Avis Budget Group during early 2026.
Embecta Faces Securities Lawsuit Over Insulin Pen Needle Revenue Claims
Investors who suffered significant losses in Embecta Corp. have until August 17, 2026, to seek lead plaintiff status in a pending class action lawsuit. Hagens Berman is investigating claims that the medical device manufacturer misled shareholders about the stability of its core insulin pen needle business throughout late 2025 and early 2026.
Investors Eye Erasca Class Action After $2.8 Billion Market Loss
More than $2.8 billion in market value evaporated at Erasca, Inc. following revelations of patent disputes and a patient death linked to its lead oncology candidate, ERAS-0015. Hagens Berman has launched a formal investigation into claims that the company misled shareholders regarding the drug's safety profile and competitive standing.
GRAIL Shareholders Face August Deadline in Securities Fraud Lawsuit
Investors who suffered heavy losses in GRAIL, Inc. following a 50% stock price collapse now have until August 4, 2026, to seek lead plaintiff status in a pending class action lawsuit. The litigation targets the company’s alleged misrepresentations regarding its high-profile NHS-Galleri cancer screening trial.
Brightspeed Ties Fiber Installation to New Customer Service Guarantee
Charlotte-based internet provider Brightspeed is attempting to eliminate the uncertainty of home network setups with a new policy that mandates technician punctuality and hands-on verification. The initiative, dubbed the Installation Guarantee, promises financial credits for missed appointments and ensures active testing before field teams depart a customer’s home.
Hagens Berman Probes Photronics Over Alleged Securities Fraud
Shareholders are facing a September 4 deadline to join a class action lawsuit against Photronics, Inc. The litigation follows claims that the company misled investors about the health of its high-end integrated circuit product line, eventually triggering a massive 36% stock price collapse last May.
Nurses Union Files Federal Charge Against Brigham and Women's Hospital
The Massachusetts Nurses Association has filed an unfair labor practice charge with the National Labor Relations Board, alleging that Brigham and Women's Hospital illegally blocked neonatal intensive care unit nurses from joining their colleagues on the picket line during the historic July 8 walkout.
Roblox Shareholders Face August Deadline in Expanding Class Action
Investors who purchased Roblox Corporation stock between October 31, 2024, and April 30, 2026, are being urged to come forward as a securities class action lawsuit against the company expands. With a lead plaintiff deadline set for August 7, 2026, the litigation centers on allegations of misleading safety disclosures.
Brand Engagement Network Reports Revenue Jump Following Cataneo Acquisition
A significant shift in scale arrives for Brand Engagement Network as its newly acquired Cataneo GmbH operations generated $5.3 million in revenue during the first half of 2026. This acquisition marks a departure from the company’s previously modest quarterly figures, signaling a transformation in its overall commercial footprint and enterprise software capacity.
Mina Aleksan Joins Florida Cancer Specialists in Trinity
Patients in Pasco County gain a new specialist as Mina Aleksan, MD, joins the Florida Cancer Specialists & Research Institute. Based at the Trinity Cancer Center, the oncologist and hematologist brings expertise in immunotherapy and targeted therapies to the statewide practice, expanding local access to complex cancer care.
Dr. Judith Joseph Named to 2026 TIME100 Creators List
As the sole physician recognized among the 2026 TIME100 Creators, psychiatrist Dr. Judith Joseph has carved a unique niche by translating clinical expertise into accessible digital content. Her inclusion highlights a shifting landscape where medical authority and social media influence intersect to reach audiences seeking mental health guidance.
Mercy Earns Global Recognition for Disability Inclusion
St. Louis-based Mercy has secured a spot as a World's Top Disability Inclusive Business for 2026. The distinction, awarded via the Disability Index, marks the health system's second consecutive year of global recognition, highlighting its ongoing shift toward dismantling workplace bias and elevating accessibility for both staff and patients.
Synopsys and Intel Foundry certify AI-driven EDA flows for 14A process
Synopsys has unveiled a suite of certified, AI-powered electronic design automation (EDA) flows tailored for Intel’s 14A process technology. Announced at the 2026 DAC Chips to Systems Conference, the collaboration aims to bridge the gap between silicon manufacturing and complex system-level performance for AI and high-performance computing architects.